Immix Biopharma Inc’s recent filing unveils that its CEO and Chairman Rachman Ilya M acquired Company’s shares for reported $5050.0 on Sep 17 ’25. In the deal valued at $2.02 per share,2,500 shares were bought. As a result of this transaction, Rachman Ilya M now holds 1,140,937 shares worth roughly $4.53 million.
Then, Morris Gabriel S bought 2,600 shares, generating $5,122 in total proceeds. Upon buying the shares at $1.97, the CFO now owns 290,659 shares.
Before that, Rachman Ilya M bought 2,178 shares. Immix Biopharma Inc shares valued at $4,999 were divested by the CEO and Chairman at a price of $2.29 per share. As a result of the transaction, Rachman Ilya M now holds 1,138,437 shares, worth roughly $4.52 million.
Price Performance Review of IMMX
On Tuesday, Immix Biopharma Inc [NASDAQ:IMMX] saw its stock fall -1.49% to $3.97. Over the last five days, the stock has lost -8.10%. Immix Biopharma Inc shares have risen nearly 101.52% since the year began. Nevertheless, the stocks have risen 80.45% over the past one year. While a 52-week high of $4.60 was reached on 11/17/25, a 52-week low of $1.34 was recorded on 04/08/25.
Levels Of Support And Resistance For IMMX Stock
The 24-hour chart illustrates a support level at 3.87, which if violated will result in even more drops to 3.77. On the upside, there is a resistance level at 4.15. A further resistance level may holdings at 4.33.
How much short interest is there in Immix Biopharma Inc?
A steep rise in short interest was recorded in Immix Biopharma Inc stocks on 2025-11-14, growing by 0.59 million shares to a total of 1.19 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-15 was 0.6 million shares. There was a rise of 49.52%, which implies that there is a positive sentiment for the stock.
